Heart EXPAND Continued Access Protocol

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

September 15, 2021

Study Completion Date

August 12, 2022

Conditions
Heart Transplant
Interventions
DEVICE

OCS Heart System

The OCS Heart System preserves the heart in a near-physiological, beating state by perfusing the heart with a warmed, donor-blood based perfusate that is supplemented with nutrients and oxygen in a controlled and protected environment

Trial Locations (12)

10032

Nyph/Cumc, New York

27710

Duke University, Durham

32803

AdventHealth Orlando, Orlando

37232

Vanderbilt Medical Center, Nashville

43210

Ohio State University, Columbus

46260

St. Vincent Cardiovascular Research Institute, Indianapolis

55407

Minneapolis Heart Institute, Minneapolis

90211

Cedars-Sinai, Los Angeles

94304

Stanford University, Palo Alto

98195

University of Washington Medical Center, Seattle

06510

Yale New Haven Hospital, New Haven

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TransMedics

INDUSTRY

NCT03835754 - Heart EXPAND Continued Access Protocol | Biotech Hunter | Biotech Hunter